← Leaderboards
Matthew Walentiny
Virginia Commonwealth University
$2,894,517
Attributed
$2,894,517
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,894,517 · 1
By mechanism
N01$2,894,517 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Frederick Gerard Moeller$65,095,599
- Michael C. Neale$26,862,438
- Kenneth Seedman Kendler$36,426,058
- Joyce A Lloyd$10,055,109
- Jenny L. Wiley$18,479,501
Others in their field
Other Rising Stars on “Abuse Liability”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Georgette Suidan · Cerevel Therapeutics, Llc$2,700,000
- Ruth Huttenhain · University Of California, San Francisco$2,364,012
- Joseph Grieco · Park Therapeutics, Inc.$2,218,061
- Ahmad El Hellani · American University Of Beirut$2,153,195
- Afshin Ghavami · Psychogenics, Inc.$2,139,595
Research focus
Abuse LiabilityNational Institute Of Drug AbusePharmaceutical PreparationsPre-ClinicalSubstance MisuseSubstance UseUnited States National Institutes Of HealthPublic HealthScienceSubstance AddictionBiomedical ResearchDrug AddictionMissionDrug Usage
Grant awards (3)
Preclinical Medications Discovery and Abuse Liability Testing for NIDA$894,744
N01 · FY2025 · DA · contact PI
PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2024.$1,026,528
N01 · FY2023 · DA · contact PI
PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA NIDA REF. NO. N01DA-22-8959. BASE AWARD.$973,245
N01 · FY2022 · DA · contact PI